Skip to content

Impact of Meditation–Based Lifestyle Modification on HRV in Outpatients With Mild to Moderate Depression: An Exploratory Study

H. Bringmann, Martin Bogdanski, G. Seifert, A. Voss

Frontiers in Psychiatry June 9, 2022 DOI: 10.3389/fpsyt.2022.808442 via Semantic Scholar

Summary

AI-generated from the abstract

A meditation and yoga program (Meditation-Based Lifestyle Modification, MBLM) improved heart rate variability (HRV) in outpatients with mild to moderate depression compared with standard clinical care. In an exploratory randomized trial, MBLM participants (22 people) showed gains in vagal tone (RMSSD) and symbolic dynamics entropy, while a minimal-treatment group (17 people on drugs only) showed almost no changes. The findings suggest that MBLM may benefit selected HRV parameters, but further 24-hour monitoring is needed to confirm long-term effects.

Study at a glance

Characteristics Randomized controlled trial Peer reviewed
Sample size 61
Population Outpatients with mild to moderate depressive disorder
Interventions Meditation-Based Lifestyle Modification (MBLM) program drugs only multimodal treatment-as-usual
Keywords Medicine Psychology
Citations 6
Key finding MBLM participants showed significant improvements in HRV indices (RMSSD and Rényi entropy) compared with the treatment-as-usual group, while the minimal-treatment group showed almost no changes.

Abstract

Background The scientific evaluation of mind-body-interventions (MBI), including yoga and meditation, has increased significantly in recent decades. However, evidence of MBI's efficacy on biological parameters is still insufficient. Objectives In this study, we used HRV analysis to evaluate a novel MBI as a treatment of outpatients with mild to moderate depressive disorder. The Meditation-Based Lifestyle Modification (MBLM) program incorporates all major elements of classical yoga, including ethical principles of yoga philosophy, breathing exercises, postural yoga, and meditation. Methods In this exploratory randomized controlled trial, we compared the changes in HRV indices of a MBLM group (N = 22) and a minimal treatment group (MINIMAL, drugs only, N = 17) with those of a multimodal treatment-as-usual group (TAU, according to best clinical practice, N = 22). Electrocardiogram (ECG) recordings were derived from a Holter monitoring device, and HRV indices have been extracted from nearly stationary 20-min periods. Results Short-term HRV analysis revealed statistically significant differences in the pre-to-post changes between MBLM and TAU. In particular, the vagal tone mediating RMSSD and the Rényi entropy of symbolic dynamics indicated HRV gains in MBLM participants compared with TAU. Almost no alterations were observed in the MINIMAL group. Conclusions Our results suggest a benefit in selected HRV parameters for outpatients with mild to moderate depression participating in the MBLM program. For further investigations, we propose analysis of complete 24-h HRV recordings and additional continuous pulse wave or blood pressure analysis to assess long-term modulations and cardiovascular effects.

Comments

No comments yet.

Log in to comment